Publikasi Scopus 926 artikel (Per 14 Maret 2022)

Faisal H.K.P., Taufik F.F., Sugihen T.T.G., Prasenohadi, Juliani T., Yunus F.
57216393050;57193061752;57226081615;55758911100;57226064151;57194486277;
Brief psychotic disorder in COVID-19 patient with no history of mental illness
2021
Journal of Infection in Developing Countries
15
6
787
790
1
Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Indonesia - Persahabatan Hospital, Jakarta, Indonesia; Department of Psychiatry, Persahabatan Hospital, Jakarta, Indonesia
Faisal, H.K.P., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Indonesia - Persahabatan Hospital, Jakarta, Indonesia; Taufik, F.F., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Indonesia - Persahabatan Hospital, Jakarta, Indonesia; Sugihen, T.T.G., Department of Psychiatry, Persahabatan Hospital, Jakarta, Indonesia; Prasenohadi, Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Indonesia - Persahabatan Hospital, Jakarta, Indonesia; Juliani, T., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Indonesia - Persahabatan Hospital, Jakarta, Indonesia; Yunus, F., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Indonesia - Persahabatan Hospital, Jakarta, Indonesia
Introduction: COVID-19 pandemic affects mental health globally. Reports showed the increase of mental illness as a response to the COVID-19 pandemic. However, the correlation between the COVID-19 and mental illness is not fully understood yet. Methodology: We reported a brief psychotic disorder in a COVID-19 patient with no history of mental illness who was hospitalized in Persahabatan Hospital, Jakarta, Indonesia. Results: Psychotic symptoms appeared five days after COVID-19 onset and laboratory tests showed elevated levels of d-dimer and fibrinogen. Conclusions: Elevated levels of d-dimer and fibrinogen suggest an ongoing COVID-19-associated coagulopathy that might cause a microdamage in the central nervous system. It might contribute to the manifestation of psychotic symptoms. The correlation between brief psychotic disorder and COVID-19 requires further investigation. Copyright © 2021 Faisal et al. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Acute psychosis; Brief psychotic disorder; COVID-19; Neuropsychiatry
alanine aminotransferase; amlodipine; ascorbic acid; aspartate aminotransferase; azithromycin; bicarbonate; C reactive protein; creatinine; D dimer; enoxaparin; ferritin; hemoglobin; hydroxychloroquine; lorazepam; oseltamivir; potassium; risperidone; sodium; urea; vitamin D; fibrin degradation product; fibrin fragment D; fibrinogen; activated partial thromboplastin time; adult; Article; auditory hallucination; blood carbon dioxide tension; blood oxygen tension; brief psychotic disorder; case report; clinical article; cold sweat; computer assisted tomography; coronavirus disease 2019; diarrhea; dry cough; dyspnea; glucose blood level; human; hypertension; lymphocyte count; male; medical history; middle aged; nasopharyngeal swab; neutrophil count; platelet count; prothrombin time; reverse tr
Journal of Infection in Developing Countries
20366590
34242187
Article
Q3
322
14136